Design, Synthesis, and SAR Studies of 4-Substituted Methoxylbenzoyl-aryl-thiazoles Analogues as Potent and Orally Bioavailable Anticancer Agents
- 10 May 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 54 (13), 4678-4693
- https://doi.org/10.1021/jm2003427
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Biological Activity of 4-Substituted Methoxybenzoyl- Aryl-Thiazole: An Active Microtubule InhibitorCancer Research, 2011
- Discovery of Novel 2-Aryl-4-benzoyl-imidazoles Targeting the Colchicines Binding Site in Tubulin As Potential Anticancer AgentsJournal of Medicinal Chemistry, 2010
- A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancerBritish Journal of Cancer, 2010
- ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculatureAnti-Cancer Drugs, 2009
- Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure−Activity RelationshipsJournal of Medicinal Chemistry, 2009
- β-Tubulin mutations in ovarian cancer using single strand conformation analysis-risk of false positive results from paraffin embedded tissuesCancer Letters, 2006
- Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defenseToxicology and Applied Pharmacology, 2005
- Pharmacological Effects of Formulation VehiclesClinical Pharmacokinetics, 2003
- Acceptor, donor, and captodative stabilization in transition states of 5-hexen-1-yl radical cyclizationsJournal of the American Chemical Society, 1986
- Tricyclic norephedrine analogs. Isomeric 9-hydroxy-10-amino-1,2,3,4,4a,9,10,10a-(trans-4a,10a)-octahydrophenanthrenesJournal of Medicinal Chemistry, 1970